Lupin launches Testosterone Gel

12 Apr 2019 Evaluate

Lupin has launched Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), having received an approval from the United States Food and Drug Administration (USFDA).

The company’s Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), is the generic equivalent of AbbVie Inc's AndroGel, 1.62%. Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), (RLD: AndroGel) had an annual sales of approximately $893 million in the US (IQVIA MAT December 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2108.70 19.05 (0.91%)
17-Dec-2025 13:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.40
Dr. Reddys Lab 1270.25
Cipla 1495.20
Zydus Lifesciences 918.00
Lupin 2108.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×